These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20724961)
1. Design, synthesis, and biological evaluation of benzylamino-methanone based cholesteryl ester transfer protein inhibitors. Abu Sheikha G; Abu Khalaf R; Melhem A; Albadawi G Molecules; 2010 Aug; 15(8):5721-33. PubMed ID: 20724961 [TBL] [Abstract][Full Text] [Related]
2. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Abu Khalaf R; Abu Sheikha G; Bustanji Y; Taha MO Eur J Med Chem; 2010 Apr; 45(4):1598-617. PubMed ID: 20116902 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors. Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400 [TBL] [Abstract][Full Text] [Related]
4. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors. Castilho MS; Guido RV; Andricopulo AD Bioorg Med Chem; 2007 Sep; 15(18):6242-52. PubMed ID: 17604633 [TBL] [Abstract][Full Text] [Related]
5. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors. Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564 [TBL] [Abstract][Full Text] [Related]
6. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia. Guérin M; Bruckert E; Dolphin PJ; Chapman MJ Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition. Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Molecular Modeling of Novel 3,5-Bis(trifluoromethyl) benzylamino Benzamides as Potential CETP Inhibitors. Khalaf RA; Awad M; Al-Qirim T; Sabbah D Med Chem; 2022; 18(4):417-426. PubMed ID: 34463228 [TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids. Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580 [TBL] [Abstract][Full Text] [Related]
10. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Chapman MJ; Le Goff W; Guerin M; Kontush A Eur Heart J; 2010 Jan; 31(2):149-64. PubMed ID: 19825813 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib. Johns DG; Chen Y; Wang SP; Castro-Perez J; Previs SF; Roddy TP Eur J Pharmacol; 2015 Sep; 762():256-62. PubMed ID: 26049012 [TBL] [Abstract][Full Text] [Related]
12. Cholesteryl ester transfer protein (CETP) inhibitors. Hunt JA; Lu Z Curr Top Med Chem; 2009; 9(5):419-27. PubMed ID: 19519458 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors. Abu Khalaf R; Sabbah D; Al-Shalabi E; Bishtawi S; Albadawi G; Abu Sheikha G Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29112287 [TBL] [Abstract][Full Text] [Related]
14. Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity. Wang S; Kussie P; Deng L; Tall A J Biol Chem; 1995 Jan; 270(2):612-8. PubMed ID: 7822286 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. Guyard-Dangremont V; Lagrost L; Gambert P J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854 [TBL] [Abstract][Full Text] [Related]
16. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits. Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610 [TBL] [Abstract][Full Text] [Related]
17. Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques. Amin SA; Adhikari N; Gayen S; Jha T J Biomol Struct Dyn; 2019 Oct; 37(17):4528-4541. PubMed ID: 30488780 [TBL] [Abstract][Full Text] [Related]
18. Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors. Wang Z; Niimi M; Ding Q; Liu Z; Wang L; Zhang J; Xu J; Fan J PLoS One; 2017; 12(8):e0180772. PubMed ID: 28767652 [TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores. Liu J; Shao PP; Guiadeen D; Krikorian A; Sun W; Deng Q; Cumiskey AM; Duffy RA; Murphy BA; Mitra K; Johns DG; Duffy JL; Vachal P Bioorg Med Chem Lett; 2021 Jan; 32():127668. PubMed ID: 33161125 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors. Abu Khalaf R; Abusaad A; Al-Nawaiseh B; Sabbah D; Albadawi G Curr Comput Aided Drug Des; 2024; 20(5):564-574. PubMed ID: 37165488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]